Guanchang Cheng

1.5k total citations · 1 hit paper
24 papers, 835 citations indexed

About

Guanchang Cheng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Guanchang Cheng has authored 24 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cancer Research. Recurrent topics in Guanchang Cheng's work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (4 papers). Guanchang Cheng is often cited by papers focused on MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (4 papers). Guanchang Cheng collaborates with scholars based in China. Guanchang Cheng's co-authors include Xiaoming Zhong, Qilin Wan, Cui‐Hua Zhao, Ruili He, Lei Zhang, Hong Yan, Yunwei Li, Zhizhong Wang, Yanming Li and Peng Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Guanchang Cheng

24 papers receiving 818 citations

Hit Papers

Hs-CRP and all-cause, cardiovascular, and cancer mortalit... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guanchang Cheng China 13 305 194 147 119 103 24 835
Changfeng Man China 15 195 0.6× 100 0.5× 115 0.8× 115 1.0× 103 1.0× 45 801
Qing Wan China 17 228 0.7× 193 1.0× 135 0.9× 61 0.5× 71 0.7× 56 848
Songtao Tang China 18 324 1.1× 263 1.4× 119 0.8× 170 1.4× 119 1.2× 64 980
Mulei Chen China 15 431 1.4× 259 1.3× 84 0.6× 89 0.7× 162 1.6× 63 875
Xiangping Chai China 17 228 0.7× 191 1.0× 127 0.9× 121 1.0× 67 0.7× 69 828
Joshua De Leon United States 18 240 0.8× 187 1.0× 118 0.8× 92 0.8× 146 1.4× 42 1.0k
Dongying Zhang China 15 292 1.0× 248 1.3× 154 1.0× 109 0.9× 47 0.5× 56 902
Xiaoquan Zhu China 19 403 1.3× 84 0.4× 206 1.4× 85 0.7× 170 1.7× 55 1.0k
Valeria Maddaloni Italy 14 280 0.9× 293 1.5× 216 1.5× 36 0.3× 108 1.0× 23 893

Countries citing papers authored by Guanchang Cheng

Since Specialization
Citations

This map shows the geographic impact of Guanchang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanchang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanchang Cheng more than expected).

Fields of papers citing papers by Guanchang Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanchang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanchang Cheng. The network helps show where Guanchang Cheng may publish in the future.

Co-authorship network of co-authors of Guanchang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Guanchang Cheng. A scholar is included among the top collaborators of Guanchang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanchang Cheng. Guanchang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Pingping, et al.. (2021). 4-phenylbutyrate exerts stage-specific effects on cardiac differentiation via HDAC inhibition. PLoS ONE. 16(4). e0250267–e0250267. 7 indexed citations
3.
Li, Tao, et al.. (2020). Wnt3a upregulation is involved in TGFβ1-induced cardiac hypertrophy. Cytokine. 138. 155376–155376. 7 indexed citations
4.
Liu, Hongyang, Zhiyong Zhang, Lei Zhang, et al.. (2020). Spiraeoside protects human cardiomyocytes against high glucose‐induced injury, oxidative stress, and apoptosis by activation of PI3K/Akt/Nrf2 pathway. Journal of Biochemical and Molecular Toxicology. 34(10). e22548–e22548. 23 indexed citations
5.
Zhang, Lei, Qilin Wan, Yuemin Zhou, et al.. (2019). Age-related and gender-stratified differences in the association between high triglyceride and risk of hyperuricemia. Lipids in Health and Disease. 18(1). 147–147. 17 indexed citations
7.
Zhong, Xiaoming, Lei Zhang, Yanming Li, et al.. (2018). Kaempferol alleviates ox-LDL-induced apoptosis by up-regulation of miR-26a-5p via inhibiting TLR4/NF-κB pathway in human endothelial cells. Biomedicine & Pharmacotherapy. 108. 1783–1789. 60 indexed citations
8.
Li, Yunwei, Xiaoming Zhong, Guanchang Cheng, et al.. (2017). Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. Atherosclerosis. 259. 75–82. 324 indexed citations breakdown →
9.
Zhao, Cui‐Hua, et al.. (2017). Fortunellin protects against high fructose-induced diabetic heart injury in mice by suppressing inflammation and oxidative stress via AMPK/Nrf-2 pathway regulation. Biochemical and Biophysical Research Communications. 490(2). 552–559. 54 indexed citations
10.
Zhong, Xiaoming, Lin Guo, Lei Zhang, et al.. (2017). Inflammatory potential of diet and risk of cardiovascular disease or mortality: A meta-analysis. Scientific Reports. 7(1). 6367–6367. 54 indexed citations
11.
Zheng, Xian, et al.. (2017). Odanacatib Inhibits Resistin-induced Cardiomyocyte Hypertrophy Through the Inactivation of ERK Signaling Pathway. International Journal of Pharmacology. 13(2). 212–217. 1 indexed citations
12.
Liu, Peng, et al.. (2016). LKB1/AMPK pathway mediates resistin-induced cardiomyocyte hypertrophy in H9c2 embryonic rat cardiomyocytes. Biomedical Reports. 4(3). 387–391. 13 indexed citations
14.
Ren, Xuequn, Wan‐Li Ma, Hong Lu, et al.. (2015). Modification of cytokine-induced killer cells with chimeric antigen receptors (CARs) enhances antitumor immunity to epidermal growth factor receptor (EGFR)-positive malignancies. Cancer Immunology Immunotherapy. 64(12). 1517–1529. 19 indexed citations
15.
Zhang, Yuan, Yanming Li, & Guanchang Cheng. (2015). Effect of low-dose diuretics on the level of serum cystatin C and prognosis in patients with asymptomatic chronic heart failure. Experimental and Therapeutic Medicine. 10(6). 2345–2350. 4 indexed citations
16.
An, Lei, et al.. (2015). Fyn arrests swainsonine-induced apoptosis in 293T cells via Akt and its phosphorylation. Genetics and Molecular Research. 14(2). 5304–5309. 5 indexed citations
17.
Zhao, Cui‐Hua, Guanchang Cheng, Ruili He, et al.. (2015). Effects of different routes of tirofiban injection on the left ventricular function and prognosis of patients with myocardial infarction treated with percutaneous coronary intervention. Experimental and Therapeutic Medicine. 9(6). 2401–2405. 6 indexed citations
18.
Zhao, Cui‐Hua, et al.. (2015). Analysis and clinical significance of microRNA-499 expression levels in serum of patients with acute myocardial infarction. Genetics and Molecular Research. 14(2). 4027–4034. 26 indexed citations
19.
Wan, Qilin, et al.. (2015). Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction.. PubMed. 8(12). 16014–9. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026